Head and neck cancer treatment and physical plasma

Clinical Plasma Medicine

Volumn 3, Issue 1, 2015, Pages 17-23

  Metelmann, Hans Robert ^a   Nedrelow, David S ^b   Seebauer, Christian ^a   Schuster, Matthias ^a   von Woedtke, Thomas ^c   Weltmann, Klaus Dieter ^c   Kindler, Stefan ^a   Metelmann, Philine Henriette ^d   Finkelstein, Steven E ^e   Von Hoff, Daniel D ^f   Podmelle, Fred ^a  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^b UNIVERSITY OF MINNESOTA   (United States)

^c LEIBNIZ INSTITUTE FOR PLASMA SCIENCE AND TECHNOLOGY   (Germany)

^d UNIVERSITY OF GREIFSWALD   (Germany)

^e 21ST CENTURY ONCOLOGY   (United States)

^f TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

Author keywords

CAP; Cold atmospheric pressure plasma; Decontamination infected cancer ulceration; Medical plasma; Reduction microbial load; Wound healing

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLEEDING; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURGERY; CANCER THERAPY; CANCER ULCERATION; CLINICAL ARTICLE; COHORT ANALYSIS; COLD ATMOSPHERIC PRESSURE PLASMA; COLLATERAL EDEMA; DRUG USE; EDEMA; FATIGUE; FEMALE; FOLLOW UP; GENERAL MEDICAL DEVICE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HYPERSALIVATION; IN VIVO STUDY; MALE; MIDDLE AGED; MUCOSAL NECROSIS; OUTCOME ASSESSMENT; PATHOGEN LOAD; PATIENT COMPLIANCE; PLASMA GAS; PLASMA SOURCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUPERFICIAL BLEEDING; TASTE DISORDER; TREATMENT DURATION; TUMOR REGRESSION; ULCER; WOUND HEALING;

EID: 84931562938     PISSN: 22128166     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cpme.2015.02.001     Document Type: Article

References (40)

1. Barrett M.T., Lenkiewicz E., Evers L., Holley T., Ruiz C., Bubendorf L., et al. Clonal evolution and therapeutic resistance in solid tumors. Front Pharmacol 2013, 28(4). Epub 2013 Jan 28.
2. Bekeschus S., von Woedtke Th, Kramer A., Weltmann K.-D., Masur K. Cold physical plasma treatment alters redoc balance in human immune cells. Plasma Med 2013, 3:267-278.
3. Brehmer F., Haenssle H.A., Daeschlein G., Ahmed R., Pfeiffer S., Görlitz A., et al. Alleviation of chronic venous leg ulcers with a hand-held dielectric barrier discharge plasma generator (PlasmaDerm® VU-2010): results of a monocentric, two-armed, open, prospective, randomized and controlled trial (NCT01415622). J Eur Acad Dermatol Venereol 2015, 29:148-155.
4. Chiorean E.G., Von Hoff D.D. Taxanes: impact on pancreatic cancer. Anticancer Drugs 2014, 25(5):584-592.
5. Daeschlein G., Scholz S., Emmert S., von Podewils S., Haase H., von Woedtke Th, et al. Plasma medicine in Dermatology: basic antimicrobial efficacy testing as prerequisite to clinical plasma therapy. Plasma Med 2012, 2:33-69.
6. Daeschlein D., Napp M., von Podewils S., Lutze S., Emmert S., Lange A., et al. In vitro susceptibility of multidrug resistant skin and wound pathogens against low temperature atmospheric pressure plasma jet (APPJ) and dielectric barrier discharge plasma (DBD). Plasma Process Polym 2014, 11:175-183.
7. Daeschlein G., Scholz S., Lutze S., Arnold A., et al. Comparison between cold plasma, electrochemotherapy and combinded therapy in a melanoma mouse model. Exp Dermatol 2013, 22:582-586.
8. Emmert S., Brehmer F., Hänßle H., Helmke A., Mertens N., Ahmed R., et al. Atmospheric pressure plasma in dermatology: ulcus treatment and much more. Clin Plasma Med 2013, 1:24-29.
9. Hasse S., Tran T.D., Hahn O., Weltmann K., Metelmann H.R., Masur K. Plasma application in human skin - molecular analyses in situ. Exp Dermatol 2014, 23:e51.
10. Haertel B., von Woedtke Th, Weltmann K.D., Lindequist U. Physical plasma - possible application in wound healing. Biomol Ther 2014, 22:477-490.
11. Heinlin J., Morfill G., Landthaler M., Stolz W., Isbary G., Zimmermann J.L., et al. Plasma medicine: possible applications in dermatology. J Deutsch Dermatol Ges 2010, 8:968-976.
12. Heinlin J., Isbary G., Stolz W., Morfill G., Landthaler M., Shimizu T., et al. Plasma applicaations in medicine with a special focus on dermatology. J Eur Acad Dermatol Venereol 2011, 25:1-11.
13. Hoffmann C., Berganza C., Zhang J. Cold atmospheric plasma: methods of production and application in dentistry and oncology. Med Gas Res 2013, 3:21.
14. Isbary G., Morfill G., Schmidt H.U., Georgi M., Ramrath K., Heinlin J., et al. A first prospective randomized controlled trial to decrease bacterial load using cold atmospheric argon plasma on chronic wounds in patients. Br J Dermatol 2010, 163:78-82.
15. Isbary G., Heinlin J., Shimizu T., Zimmermann J.L., Morfill G., Schmidt H.-U., et al. Successful and safe use of 2min cold atmospheric argon plasma in chronic wounds: results of a randomized controlled trial. Br J Dermatol 2012, 167:404-410.
16. Isbary G., Shimizu T., Li Y.-F., Stolz W., Thomas H.M., Morfill G.E., et al. Cold atmospheric plasma devices for medical issues. Expert Rev Med Dev 2013, 10:367-377.
17. Isbary G., Zimmermann J.L., Shimizu T., Li Y.-F., Morfill G.E., Thomas H.M., et al. Non-thermal plasma - more than five years of clinical experience. Clin Plasma Med 2013, 1:19-23.
18. Kalghatgi S., Kelly C., Cerchar E., Azizkhan-Clifford J. Selectivity of non-thermal atmospheric-pressure microsecond-pulsed dielectric barrier discharge plasma induced apoptosis in tumor cells over healthy cells. Plasma Med 2011, 1:249-263.
19. Keidar M., Walk R., Shahshurin A., Srinivasan P., Sandler A., Dasgupta S., et al. Cold plasma selectivity and the possibility of a paradigm shift in cancer therapy. Br J Cancer 2011, 105:1295-1301.
20. Klebes M., Ulrich C., Kluschke F., Patzel A., Vandersee S., Richter H., et al. Combined antibacterial effects of tissue-tolerable plasma and a modern conventional liquid antiseptic on chronic wound treatment. J Biophotonics 2014, 21. 10.1002/jbio.201400007.
21. Kramer A., Lademann J., Bender C., Sckell A., Hartmann B., Muench S., et al. Suitability of Tissue Tolerable Plasmas (TTP) for the management of chronic wounds. Clin Plasma Med 2013, 1:11-18.
22. Lloyd G., Friedman G., Jafri S., Schultz G., Fridman A., Harding K. Gas plasma: medical uses and developments in wound care. Plasma Process Polym 2010, 7:194-211.
23. Maisch T., Shimizu T., Li Y.-F., heinlin J., Karrer S., Morfill G., et al. Decolonisation of MRSA, S. aureus and E. coli by cold-atmospheric plasma using a porcine skin model in vitro. PLoS ONE 2012, 7:e34610.
24. 2-laser skin lesions by plasma stimulation. Am J Cosmet Surg 2012, 29:52-56.
25. Metelmann H-R, Hasse S, Podmelle F, Weltmann KD, von Woedtke T, Nedrelow D, et al. Plasma-Jet supported surgery of advanced head and neck cancer - Requirements and first steps for proof of concept. In: Proceedings of the 5th International Conference on Plasma Medicine (ICPM5), Nara/Japan; 2014. Abstract:19-AI01.
26. Partecke L.I., Evert K., Haugk J., Doering F., et al. Tissue Tolerable Plasma (TTP) induces apoptosis in pancreatic cancer cells in vitro and in vivo. BMC Cancer 2012, 12:473.
27. Ratovitski E.A., Cheng X., Yan D., Sherman J.H., Canady J., Trink B., et al. Anti-cancer therapies of 21st century: novel approach to treat human cancers using cold atmospheric plasma. Plasma Process. Polym 2014, 11:1128-1137.
28. Schlegel J., Koeritzer J., Boxhammer V. Plasma in cancer treatment. J Clin Plasma Med 2013, 1(2):2-7.
29. Schmidt A., Wende K., Bekeschus S., Bundscherer L., Barton A., Ottmüller K., et al. Non-thermal plasma treatment is associated with chnages in transcriptome of human epithelial cells. Free Radical Res 2013, 47:577-592.
30. Sensenig R., Kalghatgi S., Cerchar E., Fridman G., Shereshevsky A., Torabi B., et al. Non-thermal plasma induces apoptosis in melanoma cells via production of intracellular reactive oxygen species. Ann Biomed Eng 2011, 39(2):674-687.
31. Tabernero J., Chiorean E.G., Infante J.R., Hingorani S.R., Ganiu V., weekers C., et al. Prognostic factors of survival in a phase III trial (MPACT) of weekly nab-Paclitaxel plus Gemcitabine versus Gemcitabine alone in patients with metastatic pancreatic cancer. Oncologist 2015, Jan 12. Epub 2015 Jan 12.
32. Tiede R., Hirschberg J., Daeschlein G., von Woedtke Th, Vioel W., Emmert S. Plasma applications: a dermatological view. Contrib Plasma Phys 2014, 54:118-130.
33. Vandamme M., Robert E., Lerondel S., Sarron V., Ries D., Dozias S., et al. ROS implication in a new antitumor strategy based on non-thermal plasma. Int J Cancer 2012, 130:2185-2194.
34. von Woedtke Th Reuter S, Masur K., Weltmann K.-D. Plasmas for medicine. Phys Rep 2013, 530:291-320.
35. von Woedtke Th Metelmann H.-R., Weltmann K.-D. Clinical plasma medicine: state and perspectives og in vivo application of cold atmospheric plasma. Contrib Plasma Phys 2014, 54:104-117.
36. Weltmann K.-D., Kindel E., Brandenburg R., Meyer C., Bussiahn R., Wilke C., et al. Atmospheric pressure plasma jet for medical therapy: plasma parameters and risk estimation. Contrib Plasma Phys 2009, 49:631-640.
37. Whattcott C., Han H., Posner R.G., Von Hoff D. Tumor-stromal interactions in pancreatic cancer. Crit Rev Oncog 2013, 18(1-2):135-151.
38. Weltmann K.-D., Kindel E., von Woedtke Th, Hähnel M., Stieber M., Brandenburg R. Atmospheric-pressure plasma sources: prospective tools for plasma medicine. Pure Appl Chem 2010, 82:1223-1237.
39. Weltmann K.-D., Fricke K., Stieber M., Brandenburg R., von Woedtke Th, Schnabel U. New non-thermal atmospheric pressure plasma sources for decontamination of human extremities. IEEE Trans Plasma Sci 2012, 40:2963-2969.
40. Weltmann K.-D., Polak M., Masur K., von Woedtke Th, Winter J., Reuter S. Plasma processes and plasma sources in medicine. Contrib Plasma Phys 2012, 52:644-654.